allyl isothiocyanate (AITC)
Sponsors
Boehringer Ingelheim, Merck Sharp & Dohme LLC, Universitaire Ziekenhuizen KU Leuven
Conditions
HealthyPhysiological Responses
Phase 1
A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0001)
CompletedNCT05354453
Start: 2022-05-23End: 2023-06-14Updated: 2023-07-03
A Study to Evaluate Laser Speckle Contrast Imaging to Assess Changes in Chemical Agent-Induced Skin Blood Flow in Healthy Participants (MK-0000-420)
CompletedNCT06809569
Start: 2023-09-25End: 2023-12-15Updated: 2025-02-05